By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

A BRAIN implant has shown it can turn a person’s inner thoughts into words — but only if the user first thinks of a secret ...

A newly uncovered U.S. military report reveals that over 400 Japanese were mobilized to run the Class-B and C Yokohama war ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

The Delhi Metro Rail Corporation (DMRC) is set to introduce audio advertisements inside metro trains, beginning with the Pink ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

The Russian nuclear-powered Kirov class cruiser RFS Admiral Nakhimov was observed on August 18th departing the Sevmash ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.